These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3715802)

  • 1. Sustained proteolysis is required for human platelet activation by thrombin.
    Ruggiero M; Lapetina EG
    Thromb Res; 1986 Apr; 42(2):247-55. PubMed ID: 3715802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leupeptin selectively inhibits human platelet responses induced by thrombin and trypsin; a role for proteolytic activation of phospholipase C.
    Ruggiero M; Lapetina EG
    Biochem Biophys Res Commun; 1985 Sep; 131(3):1198-205. PubMed ID: 4052085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease and cyclooxygenase inhibitors synergistically prevent activation of human platelets.
    Ruggiero M; Lapetina EG
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3456-9. PubMed ID: 3458190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM; Limbird LE
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of a calcium dependent protease inhibitor on platelet activation and secretion.
    Rao GH; White JG; Cox CA
    Thromb Res; 1987 Sep; 47(6):625-37. PubMed ID: 3686479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A diacylglycerol kinase inhibitor, R59022, potentiates secretion by and aggregation of thrombin-stimulated human platelets.
    Nunn DL; Watson SP
    Biochem J; 1987 May; 243(3):809-13. PubMed ID: 2821994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of thrombin-induced platelet activation by leupeptin. Implications for the participation of calpain in the initiation of platelet activation.
    Brass LF; Shattil SJ
    J Biol Chem; 1988 Apr; 263(11):5210-6. PubMed ID: 2833498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators.
    Lau LF; Pumiglia K; Côté YP; Feinstein MB
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):391-400. PubMed ID: 7526841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mepacrine (quinacrine) inhibition of thrombin-induced platelet responses can be overcome by lysophosphatidic acid.
    McCrea JM; Robinson P; Gerrard JM
    Biochim Biophys Acta; 1985 Oct; 842(2-3):189-94. PubMed ID: 3931692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phospholipase C/protein kinase C pathway is involved in cathepsin G-induced human platelet activation: comparison with thrombin.
    Si-Tahar M; Renesto P; Falet H; Rendu F; Chignard M
    Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):401-8. PubMed ID: 8573071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostacyclin inhibition of phosphatidic acid synthesis in human platelets is not mediated by protein kinase C.
    Lapetina EG
    Biochem Biophys Res Commun; 1984 Apr; 120(1):37-44. PubMed ID: 6231930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombomodulin blocks the ability of thrombin to activate platelets.
    Esmon NL; Carroll RC; Esmon CT
    J Biol Chem; 1983 Oct; 258(20):12238-42. PubMed ID: 6313646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid.
    Packham MA; Livne AA; Ruben DH; Rand ML
    Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):849-56. PubMed ID: 8384448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of phospholipase C in platelet responses.
    Lapetina EG; Siess W
    Life Sci; 1983 Sep; 33(11):1011-8. PubMed ID: 6412009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
    Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW
    Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanol inhibits thrombin-induced secretion by human platelets at a site distinct from phospholipase C or protein kinase C.
    Benistant C; Rubin R
    Biochem J; 1990 Jul; 269(2):489-97. PubMed ID: 2117442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of fibrinogen receptor expression and serotonin release by leupeptin and antipain.
    Baldassare JJ; Bakshian S; Knipp MA; Fisher GJ
    J Biol Chem; 1985 Sep; 260(19):10531-5. PubMed ID: 2993278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin receptor-activating peptide releases arachidonic acid from human platelets: a comparison with thrombin and trypsin.
    McNicol A; Robson CA
    J Pharmacol Exp Ther; 1997 May; 281(2):861-7. PubMed ID: 9152395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and functional consequences of introducing inositol 1,4,5-trisphosphate into saponin-permeabilized human platelets.
    Authi KS; Evenden BJ; Crawford N
    Biochem J; 1986 Feb; 233(3):707-18. PubMed ID: 2939827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.